DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The BNP-PL is a multicenter, observational study in which patients are prospectively followed in order to investigate clinical course and management of pulmonary hypertension in Poland. All patients diagnosed with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension confirmed in right heart catheterization, will be eligible to participate in the study.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 3 months
Healthy Volunteers: f
View:

⁃ Patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension diagnosed after 1st March 2018 (incident cases) who:

• are aged \> 3 months at the time of enrollment

• fulfill the following hemodinamic criteria: mean pulmonary arterial pressure (mPAP) of 25 mm Hg or more, mean pulmonary arterial wedge pressure (PAWP) or left ventricular end-diastolic pressure (PVEDP) of 15 mm Hg or less, pulmonary vascular resistance (PVR) of 3 Woods.

⁃ Patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension diagnosed before 1st March 2018 (prevalent cases) who:

• are aged \> 3 months at the time of enrollment

• fulfill the following hemodinamic criteria: mean pulmonary arterial pressure (mPAP) of 25 mm Hg or more, mean pulmonary arterial wedge pressure (PAWP) or left ventricular end-diastolic pressure (PVEDP) of 15 mm Hg or less, pulmonary vascular resistance (PVR) of 3 Woods

Locations
Other Locations
Poland
Krakowski Szpital Specjalistyczny im. Jana Pawła II
RECRUITING
Krakow
Contact Information
Primary
Grzegorz Kopeć
grzegorzkrakow1@gmail.com
+48 12 614 33 99
Backup
Magdalena Studnicka
mstudnicka@medicalartgroup.pl
+48 602460707
Time Frame
Start Date: 2018-03-01
Estimated Completion Date: 2028-02-28
Participants
Target number of participants: 3000
Treatments
PAH adults
Patients with pulmonary arterial hypertension who are at least 18 years old at study entry
PAH children
Patients with pulmonary arterial hypertension who are at least 3 months old and are less than 18 years old at study entry
CTEPH
Patients with chronic thromboembolic pulmonary hypertension who are at least 18 years old at study entry
Related Therapeutic Areas
Sponsors
Leads: Polish Cardiology Association
Collaborators: Jagiellonian University

This content was sourced from clinicaltrials.gov